Investigating the neurochemistry of depression and the novel mood stabilising agent, ebselen, using magnetic resonance spectroscopy
RATIONALE: Magnetic resonance spectroscopy (MRS) offers a tool for investigating in vivo neurochemical changes in depression, as well as for guiding targeted drug development. Using MRS, changes to the glutamatergic system have been demonstrated in depressed patients, although results from different...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2016
|
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.729901 |